Capital Research Global Investors 13D and 13G filings for CONMED Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-13 10:29 am Sale | 2025-09-30 | 13G | CONMED CORPORATION CNMD | Capital Research Global Investors | 1,032,733 3.300% | -511,809![]() (-33.14%) | Filing |
| 2024-11-12 12:53 pm Sale | 2024-11-07 | 13G | CONMED CORPORATION CNMD | Capital Research Global Investors | 1,544,542 5.000% | -1,212,566![]() (-43.98%) | Filing |
| 2024-02-09 5:49 pm Purchase | 2024-02-07 | 13G | CONMED CORPORATION CNMD | Capital Research Global Investors | 2,757,108 9.000% | 564,714![]() (+25.76%) | Filing |
| 2023-02-13 3:32 pm Purchase | 2023-02-14 | 13G | CONMED CORPORATION CNMD | Capital Research Global Investors | 2,192,394 7.200% | 1,474,094![]() (+205.22%) | Filing |

